Abstract:Objectives: Fournier's gangrene is an aggressive, rapidly progressing, and life-threatening necrotizing fasciitis of the perineal and genital regions. Various scoring systems have been developed for predicting survival and prognosis in Fournier's gangrene. This retrospective study aimed to evaluate the effectiveness of the newly developed Fournier's gangrene mortality index (FGMI) in predicting mortality associated with Fournier's gangrene. Methods: The study included patients over the age of 18 years who were followed-up with a diagnosis of Fournier's gangrene in the general surgery clinics of three different hospitals in Şanlıurfa province between 2014 and 2024. The patients included in this study were divided into two groups: deceased (n = 20) and surviving (n = 149). In FGMI, the parameters used were age, creatinine level, albumin level, lymphocyte percentage, and neutrophil-to-lymphocyte ratio. Based on the total score and risk assessment, <5 points were categorized as low-to-moderate mortality risk and ≥5 points as high mortality risk. Results: A total of 169 patients with a diagnosis of Fournier's gangrene were included in the study; 87 were men (51.48%). The median age of all patients was 53 (40–63) years; 20 patients (11.8%) died. The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score did not show a statistically significant difference between the deceased and surviving groups (p = 0.5). Compared to the survivors, the deceased had higher neutrophil counts, neutrophil percentages, neutrophil-to-lymphocyte ratios, platelet-to-lymphocyte ratios, and C-reactive protein-to-albumin ratios, whereas lymphocyte counts, lymphocyte percentages, eosinophil counts, eosinophil percentages, monocyte counts, and monocyte percentages were lower, and these differences were statistically significant. According to receiver operating characteristic (ROC) analysis, the ROC-area under the curve for predicting mortality based on an FGMI score of ≥5 was 0.88 (95% CI: 0.80–0.95) with a sensitivity of 90% and a specificity of 70% (p < 0.001). Univariate risk analysis was performed, and the odds ratio revealed that mortality risk in patients followed-up for Fournier's gangrene with a FGMI score of ≥5 was 20 times higher (4.48–90.91) (p < 0.001). Conclusions: The results reveal that the FGMI score is a scoring system that can predict mortality at the initial clinical presentation of patients with Fournier's gangrene. Another important finding of the present study is that the LRINEC score was not sufficiently effective in predicting mortality.

[New aspects in Fournier's gangrene - a rapid review]

A contemporaneous narrative review of Fournier's gangrene

Enterostomy Can Decrease the Mortality of Patients with Fournier Gangrene

Fournier's gangrene. A clinical review

[Fournier's gangrene: case report and review of recent literature]

Fournier's gangrene: management at a regional burn center

(204) National Trends in the Treatment of Fournier's Gangrene: 2016-2019

Revisiting Fournier Gangrene: A Contemporary Epidemiological Perspective vs Perineal Cellulitis

Management of Fournier's gangrene during the Covid-19 pandemic era: make a virtue out of necessity

A contemporary case series of Fournier's gangrene at a Swiss tertiary care center-can scoring systems accurately predict mortality and morbidity?

Evaluation of Negative Pressure Wound Therapy in the Management of Fournier's Gangrene

Bibliometric insights in fournier's gangrene: Research landscapes, turning points, and global trends

Role of diverting colostomy and reconstruction in managing Fournier's gangrene—a narrative review

Fournier's gangrene -- analysis of management and outcome in south-eastern Nigeria

Management of equivocal (early) Fournier's gangrene

A life-threatening infection: Fournier's gangrene

Early Diagnosis and Treatment Outcomes of Fournier Gangrene in a Tertiary Center

An Unusual Bacterial Etiology of Fournier’s Gangrene in an Immunocompetent Patient

Fournier's Gangrene Mortality Index (FGMI): A New Scoring System for Predicting Fournier's Gangrene Mortality

Fournier's gangrene due to rectal cancer: A case report

Local wound care management for pyoderma gangrenosum